Innovative approaches to optimizing the delivery of vancomycin in individual patients
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference71 articles.
1. DeNoon D. Drug-resistant staph may get nastier: experts call for increased efforts to halt MRSA. WebMD Medical News. WebMD Web site. http://www.webmd.com/news/20060831/drug-resistant-staph-may-get-nastier. Accessed April 8, 2008.
2. Historical yearly usage of vancomycin;Kirst;Antimicrob. Agents Chemother.,1998
3. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary;Liu;Clin. Infect. Dis.,2011
4. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists;Rybak;Am. J. Health Syst. Pharm.,2009
5. Non-compartmental analysis;Gabrielsson;Methods Mol. Biol.,2012
Cited by 188 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Time-Dependent Differences in Vancomycin Sensitivity of Macrophages Underlie Vancomycin-Induced Acute Kidney Injury;Journal of Pharmacology and Experimental Therapeutics;2023-11-28
2. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02
3. Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients;The Brazilian Journal of Infectious Diseases;2023-11
4. Comparison of Vancomycin Trough–Based and 24-Hour Area Under the Curve Over Minimum Inhibitory Concentration (AUC/MIC)–Based Therapeutic Drug Monitoring in Pediatric Patients;The Journal of Pediatric Pharmacology and Therapeutics;2023-10-01
5. Mid‐dosing interval concentration is important for polymyxin B exposure and acute kidney injury in critically ill patients;CPT: Pharmacometrics & Systems Pharmacology;2023-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3